Drugs Information: Ofatumumab
Basic Information
|
||
| ID | DDInter1324 | |
| Drug Type | biotech | |
| Molecular Formula | C6480H10022N1742O2020S44 | |
| Molecular Weight | - | |
| Description | Ofatumumab is an anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. | |
| ATC Classification | L01XC10 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ofatumumab
| Severity level | ID | Name | Mechanism | Detail |
|---|